Generation of Retinal Organoids from Human Pluripotent Stem Cells
Source Galindo-Cabello et al., 2025 · University of Valladolid, Institute of Applied Ophthalmobiology (IOBA) · 10.3390/ijms26073263
Abstract
This protocol describes the generation of three-dimensional retinal organoids from human pluripotent stem cells (iPSCs and ESCs) that recapitulate the structure and function of the native retina. The organoids develop multiple retinal cell types including photoreceptors, ganglion cells, amacrine cells, bipolar cells, horizontal cells, and Müller cells, enabling disease modeling for inherited retinal diseases and screening of therapeutic interventions.
Protocol overview
26 steps across 6 phases
- 1 Fragment ESCs or iPSCs into single cells
- 2 Reaggregate cells in minimal adhesion 96-well plates
- 3 Culture aggregates for 6 days in basal medium
- 4 Add BMP4 on day 6
- 1 Continue culture with BMP4 and other retinal specification factors
- 2 Monitor optic vesicle-like structure formation
- 3 Isolate and collect neuroretinal-like structures on day 18
- 1 Transfer isolated NR structures to RPE-induction medium
- 2 Transfer to retinal maturation medium
- 3 Culture in long-term suspension or orbital rotation
- 4 Monitor retinal ganglion cell (RGC) emergence (around day 30) and photoreceptor maturation (around day 130)
- 1 Culture iPSCs at 70% confluence in essential medium without FGF2 and TGFβ
- 2 Add N2 supplement on day 2
- 3 Culture for 4 weeks in 2D to allow neural retina-like structure formation
- 4 Select and transfer NR-like structures to suspension culture
- 5 Continue long-term culture in 3D suspension
- 1 Fragment ESCs into tiny clumps
- 2 Grow clumps in mTeSR1 with Blebbistatin to form embryoid bodies
- 3 Transfer EBs to neural induction medium on day 1
- 4 Place EBs on matrigel-coated plates on day 7
- 5 Select, dissect, and transfer NR-like structures to long-term orbital culture
- 6 Culture in long-term orbital rotation
- 1 Add Notch inhibitor (DAPT) if desired to enhance photoreceptor stratification
- 2 Optionally supplement with Taurine and 9-cis-Retinal
- 3 Consider FGF pathway inhibition (SU5402) if enhanced photoreceptor development is desired
- 4 Monitor maturation with stage-specific markers (Day 100–150)
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Galindo-Cabello et al., 2025. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol